| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1191/0961203303LU496OA |
| P698 | PubMed publication ID | 14714905 |
| P2093 | author name string | J Sastre-Garriga | |
| X Montalban | |||
| P2860 | cites work | Antiphospholipid antibodies do not a syndrome make | Q28192812 |
| The clinical course of neuromyelitis optica (Devic's syndrome). | Q30581870 | ||
| Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography | Q33334045 | ||
| Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures | Q33336296 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases | Q33408807 | ||
| Cerebral venous thrombosis in systemic lupus erythematosus | Q33409386 | ||
| Anterior spinal artery syndrome in systemic lupus erythematosus | Q33433983 | ||
| Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. | Q33451037 | ||
| Antiphospholipid antibodies: a critique of their heterogeneity and hegemony | Q33491878 | ||
| beta 2-Glycoprotein I: target antigen for autoantibodies in the 'antiphospholipid syndrome'. | Q33497587 | ||
| Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model | Q33499900 | ||
| Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis | Q33651777 | ||
| A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica | Q33727402 | ||
| Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature | Q33835528 | ||
| Accelerated atheroma and anti-beta2-glycoprotein I antibodies | Q33915467 | ||
| Traumatic intracerebral venous thrombosis associated with an abnormal golf swing | Q34001185 | ||
| Proposed diagnostic criteria and nosology of acute transverse myelitis | Q34149890 | ||
| Headache in systemic lupus erythematosus: a controlled study | Q34466087 | ||
| Oculomotor palsy in six patients with systemic lupus erythematosus. A possible role of antiphospholipid syndrome. | Q34714017 | ||
| Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. | Q35467118 | ||
| Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults | Q35548094 | ||
| Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature | Q36866914 | ||
| Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Västerbotten cohort project | Q40763035 | ||
| Transverse myelopathy in SLE: clinical features and functional outcomes | Q41164491 | ||
| Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome | Q41238775 | ||
| A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus | Q41647250 | ||
| Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus | Q41837002 | ||
| Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patients | Q43933330 | ||
| Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies | Q44013915 | ||
| Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosus | Q44265237 | ||
| Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies | Q44728484 | ||
| Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study | Q45200775 | ||
| The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE. | Q46713726 | ||
| Valvular heart disease in the primary antiphospholipid syndrome | Q46730841 | ||
| Lupus anticoagulant and late onset seizures | Q46862021 | ||
| Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. | Q48144813 | ||
| CNS lupus--where do we go from here? | Q48280020 | ||
| A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? | Q48373517 | ||
| Antiphospholipid antibodies in cerebral ischemia | Q48709466 | ||
| The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies | Q48913771 | ||
| Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings | Q49226626 | ||
| Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. | Q51957611 | ||
| Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. | Q54024916 | ||
| Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis | Q57602063 | ||
| Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus | Q57602230 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 877-882 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | APS and the brain | |
| P478 | volume | 12 |
| Q48801770 | A clinically isolated syndrome: a challenging entity: multiple sclerosis or collagen tissue disorders: clues for differentiation |
| Q40321879 | Antiphospholipid syndrome and rheumatic fever: a case spanning three decades of changing concepts and common immunological mechanisms |
| Q33394654 | Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke? |
| Q34896821 | Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus |
| Q35673044 | Autoantibodies Affect Brain Density Reduction in Nonneuropsychiatric Systemic Lupus Erythematosus Patients. |
| Q35555433 | Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus |
| Q50785654 | Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center. |
| Q46115743 | Hospital based prospective longitudinal clinical and immunologic study of 179 patients of primary anti-phospholipid syndrome |
| Q38261156 | Hughes syndrome and multiple sclerosis. |
| Q35225108 | Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. |
| Q34270963 | Immunity and behavior: antibodies alter emotion |
| Q35185887 | Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus |
| Q34532993 | Lower cranial nerve palsy, aseptic meningitis and hydrocephalus: unusual presentation of primary antiphospholipid syndrome |
| Q38333909 | Neuronal Fc gamma receptor I as a novel mediator for IgG immune complex-induced peripheral sensitization |
| Q38247180 | Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers |
| Q45122099 | The pathogenesis of neural injury in animal models of the antiphospholipid syndrome |
| Q36219440 | Transient receptor potential canonical 3 (TRPC3) is required for IgG immune complex-induced excitation of the rat dorsal root ganglion neurons |
Search more.